ClinicalTrials.Veeva

Menu

Infraclavicular Perineural Dexmedetomidine

Ç

Çukurova University

Status

Completed

Conditions

The Analgesic Effects

Treatments

Drug: Dexmedetomidine
Drug: Bupivacaine

Study type

Interventional

Funder types

Other

Identifiers

NCT02550782
Mengücek gazi

Details and patient eligibility

About

Infraclavicular block is one of the peripheral nerve block used in upper extremity surgery. Adjuvant agents are used in peripheral nerve blocks to increase the duration and block quality. We investigated that the effects of patient-controlled perineural dexmedetomidine application on postoperative analgesia.

Enrollment

60 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • be undergoing distal upper extremity surgery
  • Be between 18-65 years
  • to agree to participate in research

Exclusion criteria

  • allergy to dexmedetomidine
  • AV block or bradycardia
  • being serious cardiac - liver - kidney function disorders
  • Being coagulopathy
  • neuropathy in the upper extremity
  • adrenoceptor agonists or antagonists use

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

60 participants in 2 patient groups

perineural bupivacaine
Active Comparator group
Description:
patient-controlled infraclavicular perineural bupivacaine (1% bupivacaine (marcaine), 5 ml bolus dose, infusion rate of 5 ml / h, lockout time 1 hour)
Treatment:
Drug: Bupivacaine
Drug: Dexmedetomidine
perineural dexmedetomidine
Experimental group
Description:
patient-controlled infraclavicular perineural dexmedetomidine (1% bupivacaine + 200 mic / 100cc dexmedetomidine, 5 ml bolus dose, infusion rate of 5 ml / h, lockout time 1 hour)
Treatment:
Drug: Bupivacaine
Drug: Dexmedetomidine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems